Antibodies
(monoclonal) such as
Rituxan
Balancing
therapy-related
risks and benefits
Biologics Interferon, Neupogen, Leukine ...
Bone
marrow (stem cell) transplants
Allogeneic: Mini / Autologous /
Cord
Auto versus Allo SCT
HLA-typing and Background
Harvesting / Mobilizing
stem cells
Graft vs Host Disease | Patient
stories Resources
Chemotherapy
Alphabetical
index of agents
Agents grouped by mechanism
CHOP chemotherapy
Common chemo protocols (APO...VBM)
Liposomal (encapsulated) types
Low dose (metronomic) chemotherapy
PEP-C
Outcome abstracts - Frontline
Treatment support for chemotherapy
Clinical
Trials
Search tools
Complementary and
Alternative Medicine
Elderly
patients - treatment protocols and resources
Emerging
Therapies and Targets
Pipeline with links to clinical trials
Evaluating
medical claims recognizing bias; limits of abstracts, what makes information credible.
Graft vs Host Disease
Immune-based
therapies
Lower
toxic treatments
MDS
(Myelodysplastic Syndrome)
Nanotechnology
Photopheresis
Pipeline
new agents with links to clinical trials
Pregnancy
During Lymphoma Treatment
Progress Review
Group (PRG) research objectives
Quality
of life
|
Radio-immunotherapy
Bexxar
... centers
Zevalin ... centers
Comparing Bexxar/Zevalin
RIT for bulky disease?
for Other Lymphoma Subtypes
and Indications
Radiofrequency
Ablation (RFA)?
Radiotherapy
Side
effects | Treatment
support for
Refractory
lymphomas
protocols for lymphomas resistant to standard therapies
Protocols
| Clinical
Trials
Remissions &
Response background & terms
Also Spontaneous
regressions
Rituxan
- Basics ... Side
effects ...
Check list what to expect,
bring, do.
Abstracts
| Maintenance?
Side
effects common to treatments
Splenectomy
Stem cell Transplant
Surgery
for Lymphoma? (a common question)
Treatments
& Decisions
Goals
| Types | Outcomes |
Interventions
PROTOCOL TYPES:
Standard
Off-label
... etc.
BEST PRACTICE (Standard of Care):
NCCN.org
PDF (login req.)
NCI Cancer.gov
 Treatment
decisions - factors that can influence treatment goal, type, and timing
and
Considerations
at relapse
Experts
on treatment
Treatment
outcome abstracts
Treatment Support
Treatment Timing?
Time
to Progression comparing protocols for first line treatment
of indolent NHL | Frontline
Treatment
settings frontline, relapse, survival
Watchful
Waiting
Transformation
background and treatment
Vaccines
investigational patient-specific therapeutic vaccines
Categorized
abstracts | Outcome
Data
What's
a Drug?
|
